Summary of all studies containing PUBCHEM ID 168381
Project | Study | Study_title | Subject_type | Subject_species | Metabolite_name |
---|---|---|---|---|---|
PR000280 | ST000351 | Determining the metabolic profile of wildtype, lrgAB, and atlA mutant Steptococcus mutans grown aerobically and anaerobically | Bacterial cells | Streptococcus mutans | C12 [Data] |
PR000298 | ST000380 | Temporal metabolomic responses of cultured HepG2 liver cells to high fructose and high glucose exposures (part II) | Cells | Homo sapiens | Acylcarnitine C12:0 [Data] |
PR000269 | ST000424 | Metabolomics Approach to Allograft Assessment in Liver Transplantation (part II) | Human | Homo sapiens | Dodecanoylcarnitine [Data] |
PR000348 | ST000450 | Metabolic features of chronic fatigue syndrome | Human | Homo sapiens | Dodecanoylcarnitine [Data] |
PR000357 | ST000465 | Uniquely Tumor-Selective Englerin A Profoundly Alters Lipid Metabolism in Renal Cell Carcinoma inducing ER-Stress and an Acute Inflammatory Response | Human renal cancer cells | Homo sapiens | Dodecanoylcarnitine [Data] |
PR000451 | ST000617 | Validation of the application of targeted metabolomic appraoch in the diagnosis of CFS | Human | Homo sapiens | Dodecanoylcarnitine [Data] |
PR000488 | ST000689 | Influence of Noxa knockdown on cell metabolism | Human | Homo sapiens | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ [Data] |
PR000414 | ST000692 | Metabolites produced by strains associated with inflammation | Bacteria | Treponema pectinovorum | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ [Data] |
PR000165 | ST000693 | Lanthanide-mineral induced alteration of bile acid metabolism in a murine model of steatohepatitis (part II) | Mouse | Mus musculus | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ [Data] |
PR000165 | ST000693 | Lanthanide-mineral induced alteration of bile acid metabolism in a murine model of steatohepatitis (part II) | Mouse | Mus musculus | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ [Data] |
PR000166 | ST000694 | Differences in bile acids composition between ASCL5 knockout and floxed mice. | Mouse | Mus musculus | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ [Data] |
PR000166 | ST000694 | Differences in bile acids composition between ASCL5 knockout and floxed mice. | Mouse | Mus musculus | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ [Data] |
PR000492 | ST000695 | Pilot metabolomics study of aromatase inhibitor associated arthralgias | Human | Homo sapiens | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ [Data] |
PR000492 | ST000695 | Pilot metabolomics study of aromatase inhibitor associated arthralgias | Human | Homo sapiens | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ [Data] |
PR000493 | ST000696 | Brain-Immune system-Gut Interaction in Chronic Mild Stress (CMS +/- Lacto) | Mouse | Mus musculus | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ [Data] |
PR000493 | ST000696 | Brain-Immune system-Gut Interaction in Chronic Mild Stress (CMS +/- Lacto) | Mouse | Mus musculus | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ [Data] |
PR000502 | ST000705 | Slow Aging Mice Plasma Metabolomics | Mouse | Mus musculus | LAUROYLCARNITINE (M+H)+ [Data] |
PR000518 | ST000721 | Metabolomic Profiles of Recovery from Traumatic Brain Injury | Human | Homo sapiens | LAUROYLCARNITINE (M+H)+ [Data] |
PR000519 | ST000722 | Metabolomics of Diapause in Aedes albopictus | Insect | Aedes albopictus | LAUROYLCARNITINE (M+H)+ [Data] |
PR000521 | ST000724 | Red squirrels age related changes | Animal | Tamiasciurus hudsonicus | LAUROYLCARNITINE (M+H)+ [Data] |
PR000522 | ST000725 | Metabolome, body composition, and muscle performance in children | Human | Homo sapiens | LAUROYLCARNITINE (M+H)+ [Data] |
PR000523 | ST000726 | Polycystic Ovarian Syndrome(PCOS) metabolomics | Human | Homo sapiens | LAUROYLCARNITINE (M+H)+ [Data] |
PR000535 | ST000741 | Metabolite-phenotype link in X-linked Adrenoleukodystrophy (fibroblast cell culture) | Human | Homo sapiens | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ [Data] |
PR000535 | ST000741 | Metabolite-phenotype link in X-linked Adrenoleukodystrophy (fibroblast cell culture) | Human | Homo sapiens | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ [Data] |
PR000536 | ST000743 | Metabolomics of bariatric weight loss | Human | Homo sapiens | LAUROYLCARNITINE (M+H)+ [Data] |
PR000537 | ST000744 | Metabolomics of intensive weight management clinic (IWMC) weight loss | Human | Homo sapiens | LAUROYLCARNITINE (M+H)+ [Data] |
PR000541 | ST000751 | Mouse placentas-DEHP exposure | Mouse | Mus musculus | LAUROYLCARNITINE (M+H)+ [Data] |
PR000547 | ST000758 | Effects of caloric restriction in HCR/LCR rats | Rat | Rattus norvegicus | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ [Data] |
PR000551 | ST000763 | Untargeted metabolomics and lipidomics of scleroderma PAH discovery cohort | Human | Homo sapiens | LAUROYLCARNITINE (M+H)+ [Data] |
PR000561 | ST000775 | Michigan Biomarkers for Refractory Depression (Bluebird) metabolomics pilot study | Human | Homo sapiens | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ [Data] |
PR000583 | ST000818 | Integrated nutrigenomic and metabolomic analysis of Africans with variable diet | HUMAN | Homo sapiens | LAUROYLCARNITINE (M+H)+ [Data] |
PR000510 | ST000823 | Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm (part II) | HUMAN | Homo sapiens | LAUROYLCARNITINE (M+H)+ [Data] |
PR000627 | ST000903 | Pharmacometabolomic analysis of rat hippocampus and plasma in response to chronic stress and albiflorin treament | Animal | Rattus norvegicus | Dodecanoylcarnitine [Data] |
PR000635 | ST000919 | Investigating Eicosanoids Implications on the Blood Pressure Response to Thiazide Diuretics | Human | Homo sapiens | Dodecanoylcarnitine_R1 [Data] |
PR000635 | ST000919 | Investigating Eicosanoids Implications on the Blood Pressure Response to Thiazide Diuretics | Human | Homo sapiens | Dodecanoylcarnitine_R2 [Data] |
PR000651 | ST000946 | Untargeted Metabolomics of T1 Participants | Human | Homo sapiens | DODECANOYLCARNITINE (M+H) [Data] |
PR000721 | ST001076 | Multi-platform metabolomics data from Ndufs4-/- skeletal muscles (part - I) | Mammal | Mus musculus | CAR(12:0) [Data] |
PR000721 | ST001077 | Multi-platform metabolomics data from Ndufs4-/- skeletal muscles (part-II) | Mammal | Mus musculus | CAR(12:0) [Data] |
PR000902 | ST001325 | Obesity and Poor Diet as Susceptibility Factors for Secondhand Smoke in Childhood Asthma | Human | Homo sapiens | Car(12:0) [Data] |
PR000947 | ST001383 | Investigating exposures and health impacts of endocrine disrupting chemicals among inner-city children. | Human | Homo sapiens | Car(12:0)@9.00 [Data] |
PR000947 | ST001383 | Investigating exposures and health impacts of endocrine disrupting chemicals among inner-city children. | Human | Homo sapiens | Car(12:0)@9.12 [Data] |
PR001047 | ST001637 | A Metabolome Atlas of the Aging Mouse Brain | Mammal | Mus musculus | ACar 12:0; [Data] |
PR001072 | ST001669 | Serum metabolome of Guangzhou Nutrition and Health Study (GNHS) | Human | Homo sapiens | Dodecanoylcarnitine [Data] |
PR001074 | ST001683 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. | Mammal | Mus musculus | LAUROYLCARNITINE [Data] |
PR001115 | ST001754 | Metabolomic Analysis of Canine Diabetes (part-II) | Mammal | Canis lupus familiaris | Dodecanoylcarnitine [Data] |
PR001133 | ST001780 | Comparative analysis of metabolomic profiles in cerebrospinal fluid before and after endurance exercise | Human | Homo sapiens | Dodecanoylcarnitine [Data] |
PR001133 | ST001789 | Acute metabolomic changes of plasma in response to endurance exercise | Human | Homo sapiens | Dodecanoylcarnitine [Data] |
PR001139 | ST001796 | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib | Mammal | Mus musculus | CAR 12:0 [Data] |
PR001180 | ST001869 | WNK463 Inhibition on Right Ventricular metabolomics | Mammal | Rattus norvegicus | laurylcarnitine (C12) [Data] |
PR001180 | ST001870 | Effects of GP130 Antagonism on Right Ventricular Metabolism in Monocrotaline Rats | Mammal | Rattus norvegicus | laurylcarnitine (C12) [Data] |
PR001047 | ST001888 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Mammal | Mus musculus | ACar 12:0; [Data] |
PR001213 | ST001922 | Sublytic membrane attack complex drives glycolysis and mitochondrial dysfunction with inflammatory consequences in human monocyte-derived macrophages | Human | Homo sapiens | Dodecanoylcarnitine [Data] |
PR001222 | ST001933 | Absolute quantification of plasma cytokines and metabolome reveals the glycylproline regulating antibody-fading in convalescent COVID-19 patients | Human | Homo sapiens | CAR 12:0 [Data] |
PR001235 | ST001948 | Metabolites Associated with Gestational Diabetes in Plasma | Human | Homo sapiens | CAR 12:0 [Data] |
PR001235 | ST001948 | Metabolites Associated with Gestational Diabetes in Plasma | Human | Homo sapiens | CAR 12:1 [Data] |
PR001287 | ST002027 | Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Serum/HILIC) | Human | Homo sapiens | Lauroyl-L-carnitine [Data] |
PR001287 | ST002028 | Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Stool/HILIC) | Human | Homo sapiens | Lauroyl-L-carnitine [Data] |
PR001048 | ST002088 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema | Human | Homo sapiens | laurylcarnitine (C12) [Data] |
PR000907 | ST002089 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Human | Homo sapiens | laurylcarnitine (C12) [Data] |
PR001366 | ST002153 | Data from plasma metabolome analysis of APP-KI and Wild type mice treated with B. breve MCC1274 | Mammal | Mus musculus | Lauroylcarnitine [Data] |
PR001432 | ST002244 | Metabolomics analysis of Friedreich's ataxia (FRDA) (part I) | Human | Homo sapiens | Lauroyl-L-Carnitine [Data] |
PR001451 | ST002269 | Targeted plasma metabolomics in pediatric NAFLD patients | Human | Homo sapiens | AC(12:0) [Data] |
PR001585 | ST002457 | Mouse kidney metabolomics (Whole kidney) | Mammal | Mus musculus | Lauroylcarnitine [Data] |
PR001613 | ST002498 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Human | Homo sapiens | laurylcarnitine (C12) [Data] |
PR001715 | ST002754 | Metabolomics analysis of maternal obesity model | Mammal | Mus musculus | laurylcarnitine (C12) [Data] |
PR001748 | ST002817 | Investigation of metabolism in hypertrophic cardiomyopathy - Lipidomics | Mammal | Mus musculus | Acylcarnitine(12:0) [Data] |
PR001769 | ST002827 | Multi-assay nutritional metabolomics profiling of low vitamin A status versus adequacy is characterized by reduced plasma lipid mediators among lactating women in the Philippines: A pilot study. | Human | Homo sapiens | Lauroyl-carnitine [Data] |
PR001771 | ST002829 | Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study | Human | Homo sapiens | laurylcarnitine (C12) [Data] |
PR001809 | ST002909 | Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis | Human | Homo sapiens | laurylcarnitine (C12) [Data] |
PR001890 | ST003038 | Untargeted lipidomics of WT and Cyp2c44(-/-) mice liver. | Mammal | Mus musculus | CAR 12:0 (344.28009@3.175) [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Lauroyl-L-carnitine C12 PARENT [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Lauroyl-L-carnitine C13-label-1 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Lauroyl-L-carnitine C13-label-10 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Lauroyl-L-carnitine C13-label-11 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Lauroyl-L-carnitine C13-label-12 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Lauroyl-L-carnitine C13-label-13 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Lauroyl-L-carnitine C13-label-14 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Lauroyl-L-carnitine C13-label-15 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Lauroyl-L-carnitine C13-label-16 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Lauroyl-L-carnitine C13-label-17 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Lauroyl-L-carnitine C13-label-18 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Lauroyl-L-carnitine C13-label-19 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Lauroyl-L-carnitine C13-label-2 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Lauroyl-L-carnitine C13-label-3 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Lauroyl-L-carnitine C13-label-4 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Lauroyl-L-carnitine C13-label-5 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Lauroyl-L-carnitine C13-label-6 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Lauroyl-L-carnitine C13-label-7 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Lauroyl-L-carnitine C13-label-8 [Data] |
PR001941 | ST003148 | BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h | Cultured cells | Homo sapiens | Lauroyl-L-carnitine C13-label-9 [Data] |